全文获取类型
收费全文 | 244690篇 |
免费 | 10702篇 |
国内免费 | 564篇 |
专业分类
耳鼻咽喉 | 3399篇 |
儿科学 | 7084篇 |
妇产科学 | 5641篇 |
基础医学 | 35076篇 |
口腔科学 | 8290篇 |
临床医学 | 14665篇 |
内科学 | 55131篇 |
皮肤病学 | 6870篇 |
神经病学 | 20455篇 |
特种医学 | 5968篇 |
外国民族医学 | 3篇 |
外科学 | 28192篇 |
综合类 | 1144篇 |
一般理论 | 57篇 |
预防医学 | 27833篇 |
眼科学 | 6149篇 |
药学 | 18711篇 |
中国医学 | 1037篇 |
肿瘤学 | 10251篇 |
出版年
2023年 | 1333篇 |
2022年 | 1272篇 |
2021年 | 4418篇 |
2020年 | 2383篇 |
2019年 | 4685篇 |
2018年 | 7805篇 |
2017年 | 4849篇 |
2016年 | 4847篇 |
2015年 | 5450篇 |
2014年 | 6184篇 |
2013年 | 9368篇 |
2012年 | 15841篇 |
2011年 | 16717篇 |
2010年 | 8453篇 |
2009年 | 6132篇 |
2008年 | 13680篇 |
2007年 | 14626篇 |
2006年 | 13760篇 |
2005年 | 13430篇 |
2004年 | 12183篇 |
2003年 | 11419篇 |
2002年 | 10800篇 |
2001年 | 7114篇 |
2000年 | 7970篇 |
1999年 | 6145篇 |
1998年 | 1136篇 |
1992年 | 3020篇 |
1991年 | 2648篇 |
1990年 | 2538篇 |
1989年 | 2167篇 |
1988年 | 2024篇 |
1987年 | 1919篇 |
1986年 | 1943篇 |
1985年 | 1763篇 |
1984年 | 1291篇 |
1983年 | 1108篇 |
1979年 | 1408篇 |
1978年 | 915篇 |
1977年 | 905篇 |
1976年 | 873篇 |
1975年 | 1025篇 |
1974年 | 1322篇 |
1973年 | 1377篇 |
1972年 | 1283篇 |
1971年 | 1264篇 |
1970年 | 1171篇 |
1969年 | 1230篇 |
1968年 | 1268篇 |
1967年 | 1126篇 |
1966年 | 998篇 |
排序方式: 共有10000条查询结果,搜索用时 440 毫秒
61.
Martín-Nares Eduardo Zuñiga-Tamayo Diego Hinojosa-Azaola Andrea 《Clinical rheumatology》2019,38(1):97-106
Clinical Rheumatology - We aimed to estimate the frequency of overlap of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with systemic autoimmune diseases. Retrospective... 相似文献
62.
63.
Tormo Nuria Giménez Estela Martínez-Navarro María Albert Eliseo Navalpotro David Torres Ignacio Gimeno Concepción Navarro David 《European journal of clinical microbiology & infectious diseases》2022,41(4):657-662
European Journal of Clinical Microbiology & Infectious Diseases - We compared the performance of an in-house-developed flow cytometry assay for intracellular cytokine staining (FC-ICS) and a... 相似文献
64.
65.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献66.
67.
Talita da Silva Mendes de Farias Ariclécio Cunha de Oliveira Sandra Andreotti Fernanda Gaspar do Amaral Patrícia Chimin André Ricardo Alves de Proença Francisco Leonardo Torres Leal Rogério Antonio Laurato Sertié Amanda Baron Campana Andressa Bolsoni Lopes Arnaldo Henrique de Souza José Cipolla‐Neto Fabio Bessa Lima 《Journal of pineal research》2015,58(3):251-261
Melatonin, the main hormone produced by the pineal gland, is secreted in a circadian manner (24‐hr period), and its oscillation influences several circadian biological rhythms, such as the regulation of clock genes expression (chronobiotic effect) and the modulation of several endocrine functions in peripheral tissues. Assuming that the circadian synchronization of clock genes can play a role in the regulation of energy metabolism and it is influenced by melatonin, our study was designed to assess possible alterations as a consequence of melatonin absence on the circadian expression of clock genes in the epididymal adipose tissue of male Wistar rats and the possible metabolic repercussions to this tissue. Our data show that pinealectomy indeed has impacts on molecular events: it abolishes the daily pattern of the expression of Clock, Per2, and Cry1 clock genes and Pparγ expression, significantly increases the amplitude of daily expression of Rev‐erbα, and affects the pattern of and impairs adipokine production, leading to a decrease in leptin levels. However, regarding some metabolic aspects of adipocyte functions, such as its ability to synthesize triacylglycerols from glucose along 24 hr, was not compromised by pinealectomy, although the daily profile of the lipogenic enzymes expression (ATP‐citrate lyase, malic enzyme, fatty acid synthase, and glucose‐6‐phosphate dehydrogenase) was abolished in pinealectomized animals. 相似文献
68.
A. Hochsprung S. Escudero-Uribe A.J. Ibáñez-Vera G. Izquierdo-Ayuso 《Neurología (Barcelona, Spain)》2021,36(6):433-439
IntroductionPain is highly prevalent in patients with multiple sclerosis (MS); it is chronic in 50% of cases and is classified as nociceptive, neuropathic, or mixed-type. Pain affects quality of life, sleep, and the activities of daily living. Electrotherapy is an interesting alternative or complementary treatment in the management of pain in MS, with new innovations constantly appearing.Material and methodsThis study evaluates the effectiveness of treatment with monopolar dielectric transmission of pulsed electromagnetic fields (PEMF) for pain associated with MS. We performed a randomised, placebo-controlled clinical trial including 24 patients, who were assessed with the Brief Pain Inventory, the Multiple Sclerosis International Quality of Life questionnaire, the Beck Depression Inventory, and the Modified Fatigue Impact Scale.ResultsStatistically significant improvements were observed in maximum and mean pain scores, as well as in the impact of pain on work, personal relationships, and sleep and rest. Not significant differences were found between the treatment and placebo groups.ConclusionsTreatment with PEMF may be effective in reducing pain in patients with MS, although further research is necessary to confirm its effectiveness over placebo and to differentiate which type of pain may be more susceptible to this treatment. 相似文献
69.
70.